What is Cognixion?
Cognixion develops transformative assistive communication and smart home control applications leveraging noninvasive brain-computer interfaces. Their flagship products, such as Axon-R and Speakprose 3, are designed to empower users with disabilities, bridging the gap between neuroscience, artificial intelligence, and practical accessibility. By collaborating with healthcare providers and researchers, Cognixion is creating clinical applications that aim to significantly improve the quality of life and advance human potential through its pioneering neurotechnology.
How much funding has Cognixion raised?
Cognixion has raised a total of $17.1M across 2 funding rounds:
Angel/Seed
$13M
Debt
$4M
Angel/Seed (2021): $13M with participation from Amazon Alexa Fund, Prime Movers Lab, Volta Circle, and Northwell Health
Debt (2026): $4.1M, investors not publicly disclosed
Key Investors in Cognixion
Amazon Alexa Fund
The Amazon Alexa Fund is Amazons venture capital fund investing in artificial intelligence, voice technology, frontier tech, robotics, and IoT across consumer, enterprise, healthcare, and other sectors.
Prime Movers Lab
Prime Movers Lab is a venture capital firm that focuses on funding breakthrough scientific startups aimed at transforming industries and improving lives. They seek to support founders with innovative ideas and a growth mentality, helping them realize their ambitious plans.
Volta Circle
Volta Circle is an evergreen venture capital fund that focuses on technology-driven solutions aimed at transforming linear economic systems into circular ones. Targeting seed to Series A investments, Volta Circle operates globally with a focus on Europe, the US, and India, investing in sectors such as advanced recycling, green chemicals, and sustainable materials.
What's next for Cognixion?
The substantial enterprise-level funding Cognixion has garnered signals a pivotal growth phase for the company. This capital infusion is expected to accelerate the development and deployment of their innovative AI-driven accessibility tools. With a focus on expanding their clinical applications and enhancing their neurotechnology platforms, Cognixion is well-positioned to solidify its market leadership and further its mission of empowering individuals with complex disabilities through cutting-edge technology. The strategic backing from key investors suggests a strong belief in Cognixion's potential to disrupt the assistive technology and healthcare sectors.
See full Cognixion company page
